Literature DB >> 15326291

Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.

Mathew T Mizwicki1, Don Keidel, Craig M Bula, June E Bishop, Laura P Zanello, Jean-Marie Wurtz, Dino Moras, Anthony W Norman.   

Abstract

Structural and molecular studies have shown that the vitamin D receptor (VDR) mediates 1alpha,25(OH)2-vitamin D3 gene transactivation. Recent evidence indicates that both VDR and the estrogen receptor are localized to plasma membrane caveolae and are required for initiation of nongenomic (NG) responses. Computer docking of the NG-specific 1alpha,25(OH)2-lumisterol to the VDR resulted in identification of an alternative ligand-binding pocket that partially overlaps the genomic pocket described in the experimentally determined x-ray structure. Data obtained from docking five different vitamin D sterols in the genomic and alternative pockets were used to generate a receptor conformational ensemble model, providing an explanation for how VDR and possibly the estrogen receptor can have genomic and NG functionality. The VDR model is compatible with the following: (i) NG chloride channel agonism and antagonism; (ii) variable ligand-stabilized trypsin digest banding patterns; and (iii) differential transcriptional activity, employing different VDR point mutants and 1alpha,25(OH)2-vitamin D3 analogs. Copyright 2004 The National Academy of Sciencs of the USA

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326291      PMCID: PMC516488          DOI: 10.1073/pnas.0403606101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model.

Authors:  Anthony W Norman; Mathew T Mizwicki; Derek P G Norman
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

2.  Studies on vitamin D and its analogs. VIII. 3-Deoxy-1alpha, 25-dihydroxyvitamin D3, a potent new analog of 1alpha, 25-(OH) 2-D3.

Authors:  W H Okamura; M N Mitra; D A Procsal; A W Norman
Journal:  Biochem Biophys Res Commun       Date:  1975-07-08       Impact factor: 3.575

3.  Conformational equilibria in vitamin D. Synthesis of 1beta-hydroxyvitamin D3.

Authors:  M Sheves; N Friedman; Y Mazur
Journal:  J Org Chem       Date:  1977-10-28       Impact factor: 4.354

4.  A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction.

Authors:  Anthony W Norman; Christopher J Olivera; Fátima R M Barreto Silva; June E Bishop
Journal:  Biochem Biophys Res Commun       Date:  2002-11-01       Impact factor: 3.575

5.  Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells.

Authors:  J M Caffrey; M C Farach-Carson
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

6.  Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology.

Authors:  Ali Pedram; Mahnaz Razandi; Mark Aitkenhead; Christopher C W Hughes; Ellis R Levin
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

7.  The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.

Authors:  Thi-Minh Nguyen; Michèle Lieberherr; Janine Fritsch; Huguette Guillozo; Maria Laura Alvarez; Zohra Fitouri; Frederic Jehan; Michèle Garabédian
Journal:  J Biol Chem       Date:  2003-12-09       Impact factor: 5.157

8.  Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.

Authors:  A W Norman; R Bouillon; M C Farach-Carson; J E Bishop; L X Zhou; I Nemere; J Zhao; K R Muralidharan; W H Okamura
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor.

Authors:  Laura P Zanello; Anthony W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

10.  1H nuclear magnetic resonance studies of the conformations of vitamin D compounds in various solvents.

Authors:  B Helmer; H K Schnoes; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1985-09       Impact factor: 4.013

View more
  46 in total

Review 1.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

Review 2.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

Review 3.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

4.  New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.

Authors:  Mathew T Mizwicki; Craig M Bula; June E Bishop; Anthony W Norman
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03       Impact factor: 4.292

Review 5.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

6.  Identification of a new hormone-binding site on the surface of thyroid hormone receptor.

Authors:  P C T Souza; A C Puhl; L Martínez; R Aparício; A S Nascimento; A C M Figueira; P Nguyen; P Webb; M S Skaf; I Polikarpov
Journal:  Mol Endocrinol       Date:  2014-02-19

Review 7.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

8.  1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts.

Authors:  Payal Biswas; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

Review 9.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 10.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.